These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 39302366)

  • 1. Forget About Memory: Disentangling the Amnestic Syndrome in Idiopathic Normal Pressure Hydrocephalus.
    Lingenberg A; Herrmann FR; Armand S; Péron J; Assal F; Allali G
    J Alzheimers Dis; 2024; 101(4):1205-1216. PubMed ID: 39302366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease.
    Jingami N; Asada-Utsugi M; Uemura K; Noto R; Takahashi M; Ozaki A; Kihara T; Kageyama T; Takahashi R; Shimohama S; Kinoshita A
    J Alzheimers Dis; 2015; 45(1):109-15. PubMed ID: 25428256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test.
    Kang K; Ko PW; Jin M; Suk K; Lee HW
    J Clin Neurosci; 2014 Aug; 21(8):1398-403. PubMed ID: 24836892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between high biomarker probability of Alzheimer's disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus.
    Kazui H; Kanemoto H; Yoshiyama K; Kishima H; Suzuki Y; Sato S; Suehiro T; Azuma S; Yoshimine T; Tanaka T
    J Neurol Sci; 2016 Oct; 369():236-241. PubMed ID: 27653897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus: Linking Functional Connectivity and Clinical Outcome.
    Bommarito G; Van De Ville D; Frisoni GB; Garibotto V; Ribaldi F; Stampacchia S; Assal F; Allali G; Griffa A
    J Alzheimers Dis; 2021; 83(4):1717-1728. PubMed ID: 34459399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid amyloid beta and response of cognition to a tap test in idiopathic normal pressure hydrocephalus: a case-control study.
    Kanemoto H; Mori E; Tanaka T; Suehiro T; Yoshiyama K; Suzuki Y; Kakeda K; Wada T; Hosomi K; Kishima H; Kazui H; Hashimoto M; Ikeda M
    Int Psychogeriatr; 2023 Sep; 35(9):509-517. PubMed ID: 34399871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
    Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V
    J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontal Behavior Syndromes in Idiopathic Normal Pressure Hydrocephalus as a Function of Alzheimer's Disease Biomarker Status.
    Niermeyer M; Gaudet C; Malloy P; Piryatinsky I; Salloway S; Klinge P; Lee A
    J Int Neuropsychol Soc; 2020 Oct; 26(9):883-893. PubMed ID: 32430087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.
    Manniche C; Hejl AM; Hasselbalch SG; Simonsen AH
    J Alzheimers Dis; 2019; 68(1):267-279. PubMed ID: 30741681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-Point Dynamic Observation of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus.
    Jingami N; Uemura K; Asada-Utsugi M; Kuzuya A; Yamada S; Ishikawa M; Kawahara T; Iwasaki T; Atsuchi M; Takahashi R; Kinoshita A
    J Alzheimers Dis; 2019; 72(1):271-277. PubMed ID: 31561378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of amyloid PET scan in normal pressure hydrocephalus.
    Jang H; Park SB; Kim Y; Kim KW; Lee JI; Kim ST; Lee KH; Kang ES; Choe YS; Seo SW; Kim HJ; Kim YJ; Yoon CW; Na DL
    J Neurol; 2018 Jan; 265(1):63-73. PubMed ID: 29128930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of coexistence of Alzheimer's disease in idiopathic normal pressure hydrocephalus using ELISA analyses for CSF biomarkers.
    Lim TS; Choi JY; Park SA; Youn YC; Lee HY; Kim BG; Joo IS; Huh K; Moon SY
    BMC Neurol; 2014 Apr; 14():66. PubMed ID: 24690253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.
    Chen Z; Liu C; Zhang J; Relkin N; Xing Y; Li Y
    Fluids Barriers CNS; 2017 May; 14(1):13. PubMed ID: 28486988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral blood flow and Alzheimer's disease-related biomarkers in cerebrospinal fluid in idiopathic normal pressure hydrocephalus.
    Azuma S; Kazui H; Kanemoto H; Suzuki Y; Sato S; Suehiro T; Matsumoto T; Yoshiyama K; Kishima H; Shimosegawa E; Tanaka T; Ikeda M
    Psychogeriatrics; 2019 Nov; 19(6):527-538. PubMed ID: 30916850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.
    Jeppsson A; Wikkelsö C; Blennow K; Zetterberg H; Constantinescu R; Remes AM; Herukka SK; Rauramaa T; Nagga K; Leinonen V; Tullberg M
    J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1117-1123. PubMed ID: 31167811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study.
    Abu-Rumeileh S; Giannini G; Polischi B; Albini-Riccioli L; Milletti D; Oppi F; Stanzani-Maserati M; Capellari S; Mantovani P; Palandri G; Cortelli P; Cevoli S; Parchi P
    J Alzheimers Dis; 2019; 68(2):723-733. PubMed ID: 30883350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Cerebrospinal Fluid Beta-Amyloid and Tau in Idiopathic Normal Pressure Hydrocephalus and Neurodegenerative Dementias.
    Said HM; Kaya D; Yavuz I; Dost FS; Altun ZS; Isik AT
    Clin Interv Aging; 2022; 17():467-477. PubMed ID: 35431542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome.
    Giannini G; Baiardi S; Dellavalle S; Zenesini C; Cevoli S; Danner N; Jyrkkänen HK; Rossi M; Polischi B; Quadalti C; Stefanini C; Cortelli P; Milletti D; Herukka SK; Palandri G; Leinonen V; Parchi P
    Fluids Barriers CNS; 2022 Sep; 19(1):71. PubMed ID: 36071460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White Matter Lesions May Aid in Differentiating Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease.
    Kuroda T; Honma M; Mori Y; Futamura A; Sugimoto A; Kasai H; Yano S; Hieda S; Kasuga K; Ikeuchi T; Ono K
    J Alzheimers Dis; 2022; 85(2):851-862. PubMed ID: 34864676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal Fluid Diagnostics of Alzheimer's Disease in Patients with Idiopathic Normal Pressure Hydrocephalus.
    Vanninen A; Lukkarinen H; Kokkola T; Koivisto AM; Kokki M; Musialowicz T; Hiltunen M; Zetterberg H; Leinonen V; Herukka SK; Rauramaa T
    J Alzheimers Dis; 2023; 94(2):727-736. PubMed ID: 37334597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.